Helicobacter pylori infection and systemic sclerosis-is there a link?

Joint Bone Spine

Volumn 78, Issue 4, 2011, Pages 337-340

  Radić, Mislav ^a   Kaliterna, Dušanka Martinović ^a   Radić, Josipa ^a  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

Author keywords

Helicobacter pylori; Pathogenesis; Systemic sclerosis

Indexed keywords

CAGA PROTEIN; HOST FACTOR; IMMUNOGLOBULIN G ANTIBODY; UREASE; VACUOLATING TOXIN;

ANGIOGENESIS; APOPTOSIS; AUTOIMMUNITY; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BARRETT ESOPHAGUS; CELL INVASION; CELL PROLIFERATION; CELL TRANSFORMATION; COCHRANE LIBRARY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE TRANSMISSION; EMBASE; ENVIRONMENTAL FACTOR; FECES; FLAGELLUM; GRAFT VERSUS HOST REACTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFECTION SENSITIVITY; INFLAMMATION; MEDLINE; PATHOGENESIS; PREVALENCE; RAYNAUD PHENOMENON; REFLUX ESOPHAGITIS; SALIVA; SHORT SURVEY; SYSTEMATIC REVIEW; SYSTEMIC SCLEROSIS; T LYMPHOCYTE; TOOTH PLAQUE; COMORBIDITY; MICROBIOLOGY; PATHOGENICITY; REVIEW;

COMORBIDITY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; SCLERODERMA, SYSTEMIC;

EID: 79960623621     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2010.10.005     Document Type: Short Survey

References (52)

1. Kahaleh M.B., LeRoy E.C. Autoimmunity and vascular involvement in systemic sclerosis (SSc). Autoimmunity 1999, 31:195-214.
2. Pandey J.P., LeRoy E.C. Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis. Arthritis Rheum 1998, 41:10-15.
3. Namboodiri A.M., Rocca K.M., Kuwana M., et al. Antibodies to human cytomegalovirus protein UL83 in systemic sclerosis. Clin Exp Rheumatol 2006, 24:176-178.
4. Arnson Y., Amital H., Guiducci S., et al. The role of infections in the immunopathogensis of systemic sclerosis--evidence from serological studies. Ann N Y Acad Sci 2009, 1173:627-632.
5. Lehours P., Yilmaz O. Epidemiology of Helicobacter pylori infection. Helicobacter 2007, 12(Suppl. 1):1-3.
6. Uemura N., Okamoto S., Yamamoto S., et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001, 345:784-789.
7. Magalhaes Queiroz D.M., Luzza F. Epidemiology of Helicobacter pylori infection. Helicobacter 2006, 11(Suppl. 1):1-5.
8. Ndip R.N., MacKay W.G., Farthing M.J., et al. Culturing Helicobacter pylori from clinical specimens: review of microbiologic methods. J Pediatr Gastroenterol Nutr 2003, 36:616-622.
9. Marshall B.J., Warren J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984, 1:1311-1315.
10. Andersen L.P., Colonization Infection by Helicobacter pylori in humans. Helicobacter 2007, 12(Suppl. 2):12-15.
11. Maeda S., Mentis A.F. Pathogenesis of Helicobacter pylori infection. Helicobacter 2007, 12(Suppl. 1):10-14.
12. Palli D., Masala G., Del Giudice L., et al. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int J Cancer 2007, 120:859-867.
13. Basset C., Holton J., Gatta L., et al. Helicobacter pylori infection: anything new should we know?. Aliment Pharmacol Ther 2004, 20(Suppl. 2):31-41.
14. Zhang Q.B., Etolhi G., Dawodu J.B., et al. Relationship between mucosal levels of interleukin 8 and toxinogenicity of Helicobacter pylori. Inflammopharmacology 1998, 6:109-117.
15. Chan A.O., Chu K.M., Huang C., et al. Association between Helicobacter pylori infection and interleukin 1beta polymorphism predispose to CpG island methylation in gastric cancer. Gut 2007, 56:595-597.
16. García-González M.A., Lanas A., Quintero E., et al. Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: a Nationwide Multicenter Study in Spain. Am J Gastroenterol 2007, 102:1878-1892.
17. Obonyo M., Sabet M., Cole S.P., et al. Deficiencies of myeloid differentiation factor 88, Toll-like receptor 2 (TLR2), or TLR4 produce specific defects in macrophage cytokine secretion induced by Helicobacter pylori. Infect Immun 2007, 75:2408-2414.
18. Malfertheiner P., Megraud F., O'Morain C., et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007, 56:772-781.
19. Amital H., Govoni M., Maya R., et al. Role of infectious agents in systemic rheumatic diseases. Clin Exp Rheumatol 2008, 26:27-32.
20. Ebert E.C. Gastric and enteric involvement in progressive systemic sclerosis. J Clin Gastroenterol 2008, 42:5-12.
21. Heidt P.J., Vossen J.M. Experimental and clinical gnotobiotics: influence of the microflora on graft-versus-host disease after allogeneic bone marrow transplantation. J Med 1992, 23:161-173.
22. Waer M., Ang K.K., Van der Schueren E., et al. Allogeneic bone marrow transplantation in mice after total lymphoid irradiation: influence of breeding conditions and strain of recipient mice. J Immunol 1984, 132:991-996.
23. Vossen J.M., Heidt P.J., van den Berg H., et al. Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation. Eur J Clin Microbiol Infect Dis 1990, 9:14-23.
24. Ando T., Minami M., Ishiguro K., et al. Changes in biochemical parameters related to atherosclerosis after Helicobacter pylori eradication. Aliment Pharmacol Ther 2006, 24(Suppl. 4):58-64.
25. McNamara D., O'Morain C. Gastro-oesophageal reflux disease and Helicobacter pylori: an intricate relation. Gut 1999, 45(Suppl. 1):13-17.
26. Voutilainen M., Sipponen P., Mecklin J.P., et al. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion 2000, 61:6-13.
27. Wu J.C., Sung J.J., Chan F.K., et al. Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2000, 14:427-432.
28. Reinauer S., Goerz G., Ruzicka T., et al. Helicobacter pylori in patients with systemic sclerosis: detection with the 13C-urea breath test and eradication. Acta Derm Venereol 1994, 74:361-363.
29. Graham D.Y., Malaty H.M., Evans D.G., et al. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991, 100:1495-1501.
30. Aragona P., Magazzu G., Macchia G., et al. Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjogren's syndrome. J Rheumatol 1999, 26:1306-1311.
31. Yazawa N., Fujimoto M., Kikuchi K., et al. High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: association with esophageal involvement. J Rheumatol 1998, 25:650-653.
32. Yamaguchi K., Iwakiri R., Hara M., et al. Reflux esophagitis and Helicobacter pylori infection in patients with scleroderma. Intern Med 2008, 47:1555-1559.
33. Wipff J., Allanore Y., Soussi F., et al. Prevalence of Barrett's esophagus in systemic sclerosis. Arthritis Rheum 2005, 52:2882-2888.
34. Gasbarrini A., Massari I., Serricchio M., et al. Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon. Dig Dis Sci 1998, 43:1641-1645.
35. Csiki Z., Gál I., Sebesi J., et al. Raynaud syndrome and eradication of Helicobacter pylori. Orv Hetil 2000, 141:2827-2829.
36. Savarino V., Sulli A., Zentilin P., et al. No evidence of an association between Helicobacter pylori infection and Raynaud phenomenon. Scand J Gastroenterol 2000, 35:1251-1254.
37. Sulli A., Seriolo B., Savarino V., et al. Lack of correlation between gastric Helicobacter pylori infection and primary or secondary Raynaud's phenomenon in patients with systemic sclerosis. J Rheumatol 2000, 27:1820-1821.
38. Hervé F., Cailleux N., Benhamou Y., et al. Helicobacter pylori prevalence in Raynaud's disease. Rev Med Interne 2006, 27:736-741.
39. Danese S., Zoli A., Cremonini F., et al. High prevalence of Helicobacter pylori type I virulent strains in patients with systemic sclerosis. J Rheumatol 2000, 27:1568-1569.
40. Kalabay L., Fekete B., Czirják L., et al. Helicobacter pylori infection in connective tissue disorders is associated with levels of antibodies to mycobacterial hsp65 but not to human hsp60. Helicobacter 2002, 7:250-258.
41. Radić M., Martinović Kaliterna M., Bonacin D., et al. Correlation between Helicobacter pylori infection and systemic sclerosis activity. Rheumatology (Oxford) 2010, 49:1784-1785.
42. Negrini R., Savio A., Poiesi C., et al. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 1996, 111:655-665.
43. Ferri C., Valentini G., Cozzi F., et al. Systemic sclerosis: demographic, clinical and serological features and survival in 1012 Italian patients. Medicine 2002, 81:139.
44. Randone S.B., Guiducci S., Cerinic M.M. Systemic sclerosis and infections. Autoimmun Rev 2008, 8:36-40.
45. Lobo-Yeo A., Lamb J.R. Superantigens as immunogens and tolerogens. Clin Exp Rheumatol 1993, 11:17-21.
46. Rak J.M., Pagni P.P., Tiev K., et al. Male microchimerism and HLA compatibility in French women with sclerodema: a different profile in limited and diffuse subset. Rheumatology (Oxford) 2009, 48:363-366.
47. Gilliam A.C. Scleroderma. Curr Dir Autoimmun 2008, 10:258-279.
48. Mora G.F. Systemic sclerosis: environmental factors. J Rheumatol 2009, 36:2383-2396.
49. Giacomelli R., Cipriani P., Fulminis A., et al. Gamma/delta T cells in placenta and skin: their different functions may support the paradigm of microchimerism in systemic sclerosis. Clin Exp Rheumatol 2004, 22:28-30.
50. Macchia G., Massone A., Burroni D., et al. The hsp60 protein of Helicobacter pylori: structure and immune response in patients with gastrointestinal diseases. Mol Microbiol 1993, 3:645-652.
51. Yamanishi S., Iizumi T., Watanabe E., et al. Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect Immun 2006, 74:248-256.
52. Hamamdzic D., Kasman L., LeRoy C. Role of infectious agents in the pathogenesis of systemic sclerosis. Curr Opin Rheumatol 2002, 14:694-698.